Autosomal dominant conditions are known to be associated with advanced paternal age, and it has been suggested that retinoblastoma (Rb) also exhibits a paternal age eVect due to the paternal origin of most new germline RB1 mutations. To further our understanding of the association of parental age and risk of de novo germline RB1 mutations, we evaluated the eVect of parental age in a cohort of Rb survivors in the United States. A cohort of 262 Rb patients was retrospectively identiWed at one institution, and telephone interviews were conducted with parents of 160 survivors (65.3%). We classiWed Rb survivors into three groups: those with unilateral Rb were classiWed as sporadic if they had no or unknown family history of Rb, those with bilateral Rb were classiWed as having a de novo germline mutation if they had no or unknown family history of Rb, and those with unilateral or bilateral Rb, who had a family history of Rb, were classiWed as familial. We built two sets of nested logistic regression models to detect an increased odds of the de novo germline mutation classiWcation related to older parental age compared to sporadic and familial Rb classiWcations. The modeling strategy evaluated eVects of continuous increasing maternal and paternal age and 5-year age increases adjusted for the age of the other parent. Mean maternal ages for survivors classiWed as having de novo germline mutations and sporadic Rb were similar (28.3 and 28.5, respectively) as were mean paternal ages (31.9 and 31.2, respectively), and all were signiWcantly higher than the weighted general US population means. In contrast, maternal and paternal ages for familial Rb did not diVer signiWcantly from the weighted US general population means. Although we noted no signiWcant diVerences between mean maternal and paternal ages between each of the three Rb classiWcation groups, we found increased odds of a survivor being in the de novo germline mutation group for each 5-year increase in paternal age, but these Wndings were not statistically signiWcant . Our study suggests a weak paternal age eVect for Rb resulting from de novo germline mutations consistent with the paternal origin of most of these mutations.
Introduction
Retinoblastoma (Rb) is a malignant tumor of the retina that occurs in children typically under the age of Wve. It is estimated that Rb aVects 1:15,000 births in the United States (US) (Abramson and ScheXer 2004; Lin and O'Brien 2009) . RB1 is a tumor suppressor gene involved in regulating the cell cycle, and malignant tumors occur in retinal cells with mutations in both copies of the RB1 gene. Approximately 25-35% of Rb cases are bilateral, aVecting both eyes. Individuals who inherit an RB1 mutation in an autosomal dominant manner from a parent or who have a de novo germline mutation, typically develop bilateral Rb. Approximately 65-75% of Rb cases are unilateral, occurring in only one eye, and occur sporadically when "two hits" occur in the same retinal cell (Knudson 1971) . Approximately 10% of all Rb cases can be attributed to family history with autosomal dominant inheritance. In addition, family history information and genetic testing has revealed that some unilateral cases (10-15%) involve a germline mutation in the RB1 gene (Lohmann et al.1997; Lohmann and Gallie 2004; Newsham et al. 2009; Richter et al. 2003) .
Several autosomal dominant genetic conditions are now known to be associated with advanced paternal age (generally considered to be 40-45 years of age or older) (Thacker 2004; Sartorius and Nieschlag 2010) . These include Marfan syndrome, achondroplasia, and Apert syndrome, among others. It has also been suggested that there is a paternal age eVect with Rb, albeit a weaker eVect than the conditions mentioned above (Kühnert and Nieschlag 2004; Risch et al. 1987; Sivakumaran et al., 2000) , Further, it has been estimated that 85% of new RB1 germline mutations are paternal in origin, therefore, it would be expected that older paternal age might be related to the appearance of de novo Rb (Dryja et al. 1989; Kato et al. 1994; Zhu et al. 1989) .
There have been a few studies in the literature regarding paternal/maternal age eVects but no deWnitive determination of whether these eVects are related to the occurrence of Rb (Bunin et al. 1989 , DerKinderen et al. 1990 Johnson et al. 2009; Matsunaga et al. 1990; Moll et al. 1996; Pellié et al. 1973 , Yip et al. 2006 . This study aims to further our understanding of the association of parental age and risk of de novo germline RB1 mutations by evaluating parental age in a cohort of Rb survivors in the US. Our hypothesis is that Rb survivors with a de novo germline mutation are more likely to have a father of advanced paternal age when compared with survivors of sporadic or familial Rb, and the general population.
Subjects and methods
The retrospectively deWned cohort used for this study consists of 262 Rb patients diagnosed from January 1, 1985 through December 31, 1996 at a medical center in New York, NY. This cohort is currently part of a larger study of secondary cancer incidence and cause-speciWc mortality in long-term Rb survivors (Kleinerman et al. 2005; Yu et al. 2009 ). Hospital records were used to identify study subjects and to collect medical history and treatment data. Demographic data, including biological parental age at the birth of the Rb patient, were collected via telephone interviews conducted in 1998. Of the original 262 Rb patients, 4 did not survive after 1 year and 13 had died by the time of the interview in 1998. Therefore, parents of 245 survivors were eligible to be interviewed for the study and parents of 160 (65.3%) survivors agreed to participate. We did not identify statistically signiWcant diVerences between the respondents and non-respondents for hereditary status, year of birth or sex of their child; however, a higher proportion of respondents were Caucasian (p < 0.001) and reported a family history of Rb (p = 0.02). Family history was deWned as a Wrst or second degree relative with Rb.
We excluded one individual from the analysis who was born in 1950 because all other members of the cohort were born between 1975 and 1996. Maternal age data were not available for two survivors and paternal age for Wve survivors, but all other available data for these survivors were included. Therefore, we analyzed 159 of the 160 survivors for this study.
The cohort survivors were grouped into one of three Rb classiWcations: survivors with unilateral Rb were classiWed as sporadic if they had no or unknown family history of Rb, survivors with bilateral Rb were classiWed as having a de novo germline mutation if they had no or unknown family history of Rb, and survivors with unilateral or bilateral Rb, who had a family history of Rb, were classiWed as familial. The sporadic and de novo germline mutation classiWcations based on laterality of Rb tumors are an approximation, because mutation testing data were not available for the cohort.
In this study, we have included Rb survivors with a family history of Rb because this group likely has children at the same age as parents in the general population. Published mean maternal age data for the US are available for the years 1970-2000 (Mathews and Hamilton 2002) , however, mean paternal age data are not, so we calculated mean paternal age from public use Wles available from the US Centers for Disease Control and Prevention, National Center for Health Statistics Reproductive Statistics Branch, Division of Vital Statistics (US CDC data) for births for the years 1975-1996. We also calculated mean maternal age for each year from 1975 to 1996 and then compared these data to those published by Mathews and Hamilton (2002) and found our calculations to be accurate to within 0.1 years. Paternal age data for the US were missing for 11.1% of fathers in 1975 up to a high of 16.9% of fathers in 1991. For comparison to the mean parental ages in our cohort, we calculated a weighted mean for mean maternal and paternal age in the US general population based on the years of birth of our cohort of survivors.
Statistical analysis
Associations between categorical predictors and the three Rb classiWcation groups were assessed with either Chisquare tests or the Freeman-Halton extension of the Fisher's exact test when small expected cell frequencies were noted. Two sets of nested logistic regression models were built to look for increased odds of a de novo germline mutation classiWcation versus sporadic and familial Rb associated with increased maternal and paternal age. The Wrst modeling strategy looked for eVects of continuous increasing maternal and paternal age while controlling for diVerences in race (White, African-American, Hispanic, other/unknown) and age of the other parent. To assess nonlinear age eVects, a second set of models using parental age groupings of <30, 30-34, and ¸35 years were subsequently analyzed while controlling for diVerences in race and age of the other parent. We used parental age <30 years as our reference group because we had a limited number of fathers and mothers less than age 25. All diVerences between means were compared using either one sample t tests or one-way ANOVAs. For all tests, statistical signiWcance was declared for two tailed p values p < 0.05. All calculations were performed using SAS Enterprise Guide version 4.22, SAS version 9.2 (Cary, NC, USA).
Results
We classiWed 75 (47.2%) survivors as sporadic, 46 (28.9%) as de novo germline mutation and 38 (23.9%) as familial (Table 1) . We found no noteworthy diVerences between sex, race, year of birth, age of mother at birth, and age of father at birth for each of the three groups. Laterality and family history diVered for each of the Rb classiWcation groups by deWnition. As expected, de novo germline mutation and familial cases of Rb were more likely to be diagnosed at less than 1 year of age as compared to sporadic cases (p < 0.001).
Mean maternal and paternal ages for the de novo germline mutation classiWcation were signiWcantly higher than the weighted mean maternal (28.3 vs. 26.2 years, p = 0.003) and paternal (31.9 vs. 29.3 years p = 0.007) ages of the general US population (Table 2) . Similarly, maternal and paternal ages for the sporadic Rb classiWcation group were signiWcantly higher than the mean maternal and paternal ages of the general US population (p < 0.001 and p = 0.01, respectively). Conversely, the parental ages for the familial classiWcation group did not diVer signiWcantly from the general US population. Although the three Rb classiWcation groups did not diVer signiWcantly from each other for maternal (p = 0.2) or paternal (p = 0.3) mean ages, the mean maternal and paternal ages for both de novo and sporadic Rb groups were similar (28.3 and 28.5, and 31.9 and 31.2, respectively) whereas the mean ages for the familial parents were approximately 1.7 years younger than mothers of presumed sporadic and de novo survivors and approximately 1.8 years younger than the average age for fathers of presumed sporadic and de novo survivors.
In our analysis of continuous parental age, there was no statistically signiWcant eVect of maternal or paternal age when the odds of having a presumed de novo germline mutation were compared to the odds of having sporadic Rb or familial Rb. The odds ratios for almost all scenarios were close to 1.0, even when the analysis was adjusted for race and the age of the other parent.
When we examined the odds of having a presumed de novo germline mutation versus the odds of having familial Rb by 5-year age groups for paternal age, we found increased odds of having a de novo germline mutation versus the odds of having either sporadic Rb or familial Rb (Table 3 ). The eVect was highest for the 30-34 paternal age group but no eVects were signiWcant, even when adjusted for race and age of the other parent (Table 3) . We found a non-signiWcant increase in the odds of having a presumed de novo germline mutation versus the odds of having familial Rb, for maternal ages 30-34 (OR = 2.8 [0.9-8.8]). However, the odds for maternal age greater than 35, was reduced (OR = 0.8 [0.2-3.3]).
Discussion
In this study, we have assessed the inXuence of older parental age on Rb caused by de novo autosomal dominant mutations using a cohort of Rb survivors diagnosed and treated at one institution. To our knowledge, this is the Wrst study to evaluate parental age eVects for three diVerent categories of Rb (hereditary Rb resulting from a de novo germline mutation, sporadic Rb, and familial Rb inherited from an aVected parent), and investigate parental age diVerences between these three groups.
Although we found no signiWcant diVerences between maternal and paternal ages when comparing the three Rb groups, there was some evidence of a signal for older paternal age and the odds of a de novo germline mutation based on the modeling. We also noted that mean parental ages related to de novo germline mutations and sporadic Rb, but not familial Rb, were higher than the general population. This Wnding supports the notion that, in general, those with familial Rb reproduce at ages similar to the general population, but have a 50/50 chance of passing on the mutated RB1 allele with each pregnancy. It was not surprising to Wnd younger parental ages for familial Rb cases when compared to sporadic Rb because this was reported in a previous study (Yip et al. 2006) . However, the similarity of (Martin, et al. 2009) . If the mean age of fathers in the general population is even younger than that presented in our data, the diVerences presented between our classiWcation groups and the general population would likely be even more signiWcant. When comparing our study with previous studies regarding parental age data for Rb (see Table 4 ), it is important to note that we compared our hospital-based cohort to the general population in our analysis of mean maternal and paternal age. We did not use matched general population controls for our logistic regression analysis nor did we use incidence data for Rb in the United States. Unlike previous studies, we compared the odds of being in the de novo germline mutation classiWcation group versus the sporadic and familial Rb groups given increasing parental age in our cohort of individuals. Our comparisons of parental age to general population means were similar to Wndings reported by DerKinderen et al. (1990) and Moll et al. (1996) for de novo mutations, but in contrast to these studies, we also saw signiWcant diVerences for sporadic non-hereditary Rb.
Although our comparisons of parental age to general population means were similar to previously reported Wndings, there are several limitations to our study. The classiWcations performed for our study were accomplished by proxy with laterality and family history information. Thus, some unilateral survivors in our cohort may have a de novo mutation that predisposed them to Rb and would be misclassiWed in our study. In our cohort, we had relatively few parents over the age of 35 years making it diYcult to estimate the odds of having a child with a de novo mutation for fathers of advanced paternal age (greater than 40-45 years of age). The theory behind de novo mutations and advanced paternal age is that errors occur in mitotic divisions during male spermatogenesis (Thacker 2004; Sartorius and Nieschlag 2010) . Although our results suggested a pattern of increased odds of a de novo mutation with paternal age, we believe this is a preliminary Wnding that should be followed up with additional analysis. In addition, our study compared survivors from one referral hospital in New York City to all births in the US general population rather than to matched controls. Our study also did not include patients who died from Rb and thus may have missed more seriously aVected patients. Of the survivor's families contacted, only 65% of the cohort agreed to participate; having more subjects would allow for statistical power to determine if the patterns we observed in this analysis are valid. In addition, more complete information on subject characteristics, such as race and socioeconomic status, would allow for a more detailed analysis of potential confounders. Additional research could also consider the inXuence of other covariates such as environmental exposures of one or both parents that could increase the risk of de novo RB1 mutations (Bunin et al. 2011) . Future work regarding Rb and parental age should include mutation status gathered from genetic testing rather than by proxy with laterality and family history, since some unilateral survivors, classiWed as sporadic in our cohort, may in fact have a de novo mutation that predisposed them to Rb. Additional studies of parental age and Rb could be accomplished by randomly selecting individuals diagnosed with Rb from the general population regardless of vital status, classifying Rb patients with respect to mode of inheritance and genetic testing, and comparing the patient sample to a sample of general population controls matched to cases on birth year. A dataset that includes mutation status, rather than the by proxy classiWcations presented herein, would allow for a more precise analysis of the diVerences in parental ages of the three Rb classiWcation groups, given an adequate number of patients to achieve statistical power. Although prior studies have beneWted from larger sample sizes, we believe this is the Wrst study to include familial inherited Rb in an analysis of parental age. Familial, inherited Rb may be a more appropriate control in this study, as opposed to sporadic Rb, in that individuals with familial germline Rb mutations have children at similar ages to the general population, and Rb occurs due to the 50% risk to oVspring of an RB1 mutation carrier. This similarity in ages for the familial Rb classiWcation group and the general US population was also seen in the mean parental age data shown in Table 2 .
Overall, our Wndings show that, as previously reported for other countries, the mean parental age of Rb survivors with a presumed de novo mutation is statistically signiWcantly higher than the mean age of the general US population. The similarity of mean maternal and paternal ages for presumed de novo germline mutations as well as for presumed sporadic Rb was unexpected and deserves further attention, because there is no obvious explanation for this similarity. Our study suggests a greater paternal rather than maternal contribution to RB1 mutations, perhaps during gametogenesis, for the de novo germline mutations; however, we have insuYcient data for investigating paternal age over 40 years to test this hypothesis further. Our Wndings do not indicate statistically signiWcant eVects for advanced paternal age and thus would not be appropriate for use in genetic counseling at this time.
